tanshinone ii a has been researched along with vitamin k 3 in 4 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (vitamin k 3) | Trials (vitamin k 3) | Recent Studies (post-2010) (vitamin k 3) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 1,316 | 10 | 504 |
| Protein | Taxonomy | tanshinone ii a (IC50) | vitamin k 3 (IC50) |
|---|---|---|---|
| perilipin-5 | Homo sapiens (human) | 9.468 | |
| perilipin-1 | Homo sapiens (human) | 7.895 | |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | Homo sapiens (human) | 8.6815 | |
| Aldehyde oxidase 1 | Mus musculus (house mouse) | 0.15 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 7.96 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 7.96 | |
| Indoleamine 2,3-dioxygenase 1 | Homo sapiens (human) | 0.8925 | |
| Protein kinase C alpha type | Homo sapiens (human) | 2.2 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 3.02 | |
| Protein-glutamine gamma-glutamyltransferase 2 | Homo sapiens (human) | 2.2 | |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | 4.55 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 3.16 | |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 2.2 | |
| Aldehyde oxidase 1 | Oryctolagus cuniculus (rabbit) | 2 | |
| Aldehyde oxidase | Homo sapiens (human) | 0.2 | |
| Receptor-type tyrosine-protein phosphatase eta | Homo sapiens (human) | 2.2 | |
| Thiosulfate sulfurtransferase | Homo sapiens (human) | 1 | |
| Receptor protein-tyrosine kinase | Homo sapiens (human) | 2.2 | |
| 60 kDa chaperonin | Escherichia coli | 5.75 | |
| Aldehyde oxidase 1 | Macaca fascicularis (crab-eating macaque) | 0.11 | |
| 10 kDa chaperonin | Escherichia coli | 5.75 | |
| Aldehyde oxidase 1 | Rattus norvegicus (Norway rat) | 0.19 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
| Arora, S; Chaturvedi, A; Heuser, M; Joshi, G; Kumar, R; Patil, S | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
4 other study(ies) available for tanshinone ii a and vitamin k 3
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |
A Perspective on Medicinal Chemistry Approaches for Targeting Pyruvate Kinase M2.
Topics: Allosteric Regulation; Allosteric Site; Carrier Proteins; Chemistry, Pharmaceutical; Glycolysis; Humans; Membrane Proteins; Protein Kinase Inhibitors; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2022 |
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |